95 related articles for article (PubMed ID: 12400570)
41. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
Baldi F; Malfertheiner P
Digestion; 2003; 67(1-2):1-5. PubMed ID: 12743433
[TBL] [Abstract][Full Text] [Related]
42. Effects of lansoprazole on gastric ulcer healing and mucin content.
Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
[TBL] [Abstract][Full Text] [Related]
43. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
44. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
45. Treatment of Helicobacter pylori infection: is less more?
Howden CW
J Clin Gastroenterol; 2000 Sep; 31(2):105-6. PubMed ID: 10993423
[No Abstract] [Full Text] [Related]
46. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
[TBL] [Abstract][Full Text] [Related]
47. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
[TBL] [Abstract][Full Text] [Related]
49. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
Hoshino E; Umeda N; Sano J; Miki K; Yahagi N; Oka M; Kimura M; Miyashita H
J Clin Gastroenterol; 1995; 20 Suppl 2():S72-4. PubMed ID: 7594346
[TBL] [Abstract][Full Text] [Related]
50. An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube.
Devlin JW; Bakshi A; Bungay K; Olsen KM
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1603-11. PubMed ID: 17206948
[TBL] [Abstract][Full Text] [Related]
51. Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease.
Hatlebakk JG; Nesje LB; Hausken T; Bang CJ; Berstad A
Scand J Gastroenterol; 1995 Nov; 30(11):1053-7. PubMed ID: 8578163
[TBL] [Abstract][Full Text] [Related]
52. Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
Si JM; Cao Q; Wu JG
World J Gastroenterol; 2005 Jun; 11(22):3461-4. PubMed ID: 15948255
[TBL] [Abstract][Full Text] [Related]
53. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
Murakami M; Saita H; Takahashi Y; Kusaka S; Asagoe K; Dekigai H; Matsumoto M; Seki M; Mizuno M; Maeda S
J Clin Gastroenterol; 1995; 20 Suppl 2():S79-82. PubMed ID: 7594348
[TBL] [Abstract][Full Text] [Related]
55. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
[TBL] [Abstract][Full Text] [Related]
56. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
57. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
[TBL] [Abstract][Full Text] [Related]
59. The effect of food and antacids on lansoprazole absorption and disposition.
Delhotal-Landes B; Cournot A; Vermerie N; Dellatolas F; Benoit M; Flouvat B
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():315-20. PubMed ID: 1820900
[TBL] [Abstract][Full Text] [Related]
60. Safety of omeprazole and lansoprazole.
Colin-Jones D
Lancet; 1994 May; 343(8909):1369. PubMed ID: 7910362
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
